Zinc salts provide a novel, prolonged and rapid inhibition of gastric acid secretion

American Journal of Gastroenterology

Volumn 106, Issue 1, 2011, Pages 62-70

  Kirchhoff, Philipp ^a,b   Socrates, Thenral ^a   Sidani, Shafik ^a   Duffy, Andrew ^a   Breidthardt, Tobias ^c   Grob, Christian ^b   Viehl, Carsten T ^b   Beglinger, Christoph ^c   Oertli, Daniel ^b   Geibel, John P ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DICHLORODIHYDROFLUORESCEIN DIACETATE; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; ZINC CHLORIDE; ZINC DERIVATIVE; ZINC SULFATE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PH; CLINICAL ARTICLE; CROSSOVER PROCEDURE; DIGITAL IMAGING; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAT; STOMACH ACID SECRETION; STOMACH GLAND; STOMACH PH;

ADULT; ANIMALS; CHLORIDES; CROSS-OVER STUDIES; DISEASE MODELS, ANIMAL; FEMALE; GASTRIC ACID; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; OMEPRAZOLE; PROTON PUMP INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; RISK ASSESSMENT; STOMACH; TISSUE CULTURE TECHNIQUES; TREATMENT OUTCOME; ZINC COMPOUNDS;

EID: 78650991802     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.327     Document Type: Article

References (50)

1. Hersey SJ, Sachs G. Gastric acid secretion. Physiol Rev 1995; 75: 155-89.
2. Aihara T, Nakamura E, Amagase K et al. Pharmacological control of gastric acid secretion for the treatment of acid-related peptic disease: past, present, and future. Pharmacol Ther 2003; 98: 109-27.
3. Gardner JD, Sloan S, Miner PB et al. Meal-stimulated gastric acid secretion and integrated gastric acidity in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003; 17: 945-53.
4. Williams JL. Gastroesophageal reflux disease: clinical manifestations. Gastroenterol Nurs 2003; 26: 195-200.
5. Lehmann F, Hildebrand P, Beglinger C. New molecular targets for treatment of peptic ulcer disease. Drugs 2003; 63: 1785-97.
6. Eisen GM, Sandler RS, Murray S et al. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. Am J Gastroenterol 1997; 92: 27-31.
7. Turcotte S, Duranceau A. Gastroesophageal reflux and cancer. Thorac Surg Clin 2005; 15: 341-52.
8. Robinson M. Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases. Int J Clin Pract 2005; 59: 709-15.
9. Garnett WR. Lansoprazole: a proton pump inhibitor. Ann Pharmacother 1996; 30: 1425-36.
10. Katz PO, Hatlebakk JG, Castell DO. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole. Aliment Pharmacol Ther 2000; 14: 709-14.
11. Carlsson R, Galmiche JP, Dent J et al. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials. Aliment Pharmacol Ther 1997; 11: 473-82.
12. Kleinman L, McIntosh E, Ryan M et al. Willingness to pay for complete symptom relief of gastroesophageal reflux disease. Arch Intern Med 2002; 162: 1361-6.
13. Tytgat GN. Shortcomings of the first-generation proton pump inhibitors. Eur J Gastroenterol Hepatol 2001; 13 (Suppl 1): S29-33.
14. Gedda K, Scott D, Besancon M et al. Turnover of the gastric H+,K(+)- adenosine triphosphatase alpha subunit and its effect on inhibition of rat gastric acid secretion. Gastroenterology 1995; 109: 1134-41.
15. Diamond I, Hurley LS. Histopathology of zinc-deficient fetal rats. J Nutr 1970; 100: 325-9.
16. Elmes ME, Jones JG. Ultrastructural studies on Paneth cell apoptosis in zinc deficient rats. Cell Tissue Res 1980; 208: 57-63.
17. Fong LY, Lee JS, Chan WC et al. Zinc deficiency and the development of esophageal and forestomach tumors in Sprague-Dawley rats fed precursors of N-nitroso-N-benzylmethylamine. J Natl Cancer Inst 1984; 72: 419-25.
18. Ng WL, Fong LY, Ma L et al. Dietary zinc deficiency and tumorigenesis: a scanning electron microscope study. J Electron Microsc (Tokyo) 1984; 33: 344-8.
19. Sunderman FW Jr. The Influence of zinc on apoptosis. Ann Clin Lab Sci 1995; 25: 134-42.
20. Cho CH, Fong LY, Ma PC et al. Zinc deficiency: its role in gastric secretion and stress-induced gastric ulceration in rats. Pharmacol Biochem Behav 1987; 26: 293-7.
21. Frommer DJ. The healing of gastric ulcers by zinc sulphate. Med J Aust 1975; 2: 793-6.
22. Watanabe T, Arakawa T, Fukuda T et al. Zinc deficiency delays gastric ulcer healing in rats. Dig Dis Sci 1995; 40: 1340-4.
23. Naess K. Zinc in the treatment of stomach ulcer. Tidsskr Nor Laegeforen 1976; 96: 1334.
24. Schettino T, Kohler M, Fromter E. Membrane potentials of individual cells of isolated gastric glands of rabbit. Pflugers Arch 1985; 405: 58-65.
25. McDaniel N, Lytle C. Parietal cells express high levels of Na-K-2Cl cotransporter on migrating into the gastric gland neck. Am J Physiol 1999; 276 (5 Part 1): G1273-8.
26. Geibel JP, Wagner CA, Caroppo R et al. The stomach divalent ion-sensing receptor scar is a modulator of gastric acid secretion. J Biol Chem 2001; 276: 39549-52.
27. Dufner MM, KirchhoffP, Remy C et al. the calcium-sensing receptor (CaSR) acts as a modulator of gastric acid secretion in freshly isolated human gastric glands. Am J Physiol Gastrointest Liver Physiol 2005; 289: G1084-90.
28. Paradiso AM, Negulescu PA, Machen TE. Na+-H+ and Cl(-)-OH-(HCO3-) exchange in gastric glands. Am J Physiol 1986; 250 (4 Part 1): G524-34.
29. Geibel JP, Wagner C. An update on acid secretion. Rev Physiol Biochem Pharmacol 2006; 156: 45-60.
30. Hersey SJ, Sachs G. Gastric acid secretion. Physiol Rev 1995; 75: 155-89.
31. Sachs G, Munson K, Hall K et al. Gastric H+,K(+)-ATPase as a therapeutic target in peptic ulcer disease. Dig Dis Sci 1990; 35: 1537-44.
32. Ma TK, Lam YY, Tan VP et al. Impact of genetic and acquired alteration in cytochrome P450 system on pharmacologic and clinical response to clopidogrel. Pharmacol Ther 2010; 125: 249-59.
33. Grigolon A, Cantu P, Savojardo D et al. Esophageal acid exposure on proton pump inhibitors in unselected asymptomatic gastroesophageal reflux disease patients. J Clin Gastroenterol 2008; 42: 969-73.
34. Chey WD, Mody RR, Izat E. Patient and physician satisfaction with proton pump inhibitors (PPIs): are there opportunities for improvement? Dig Dis Sci 2010; DOI: 10.1007 / s10620-010-1209-2.
35. Song Y, Leonard SW, Traber MG et al. Zinc deficiency affects DNA damage, oxidative stress, antioxidant defenses, and DNA repair in rats. J Nutr 2009; 139: 1626-31.
36. Ali T, Roberts DN, Tierney WM. Long-term safety concerns with proton pump inhibitors. Am J Med 2009; 122: 896-903.
37. Cho CH, Ogle CW, Dai S. Effects of zinc sulphate pretreatment on gastric acid secretion and lesion formation in rats infused intravenously with graded doses of methacholine. Pharmacology 1978; 17: 32-8.
38. Cho CH, Ogle CW, Dai S. Effects of zinc chloride on gastric secretion and ulcer formation in pylorus-occluded rats. Eur J Pharmacol 1976; 38: 337-41.
39. Escolar G, Bulbena O. Zinc compounds, a new treatment in peptic ulcer. Drugs Exp Clin Res 1989; 15: 83-9.
40. Bulbena O, Esplugues JV, Escolar G et al. Zinc acexamate inhibits gastric acid and pepsinogen secretion in the rat. J Pharm Pharmacol 1990; 42: 252-6.
41. McLeay LM, Smith BL. Effects of intraruminal administration of zinc on gastric acid secretion in sheep. Res Vet Sci 1977; 23: 243-5.
42. Puscas I, Sturzu L, Buzas G. Effect of ZnSO4 upon gastric acid secretion and carbonic anhydrase. Int J Clin Pharmacol Ther Toxicol 1985; 23: 609-12.
43. Hershfinkel M, Moran A, Grossman N et al., A zinc-sensing receptor triggers the release of intracellular Ca2+ and regulates ion transport. Proc Natl Acad Sci USA. 2001, 98, 11749-54.
44. Inoue K, Branigan D, Xiong ZG. Zinc-induced neurotoxicity mediated by transient receptor potential melastatin 7 channels. J Biol Chem 2010; 285: 7430-9.
45. Lewis MR, Kokan L. Zinc gluconate: acute ingestion. J Toxicol Clin Toxicol 1998; 36: 99-101.
46. Inoue K, Branigan D, Xiong ZG. Zinc-induced neurotoxicity mediated by transient receptor potential melastatin 7 channels. J Biol Chem 2010; 285: 7430-9.
47. Hoque KM, Rajendran VM, Binder HJ. Zinc inhibits cAMP-stimulated Cl secretion via basolateral K-channel blockade in rat ileum. Am J Physiol Gastrointest Liver Physiol 2005; 288: G956-63.
48. Yukutake Y, Hirano Y, Suematsu M et al. Rapid and reversible inhibition of aquaporin-4 by zinc. Biochemistry 2009; 48: 12059-61.
49. Beharier O, Etzion Y, Katz A et al. Crosstalk between L-type calcium channels and ZnT-1, a new player in rate-dependent cardiac electrical remodeling. Cell Calcium 2007; 42: 71-82.
50. Dammann HG, Burkhardt F. Pantoprazole versus omeprazole: Influence on meal-stimulated gastric acid secretion. Eur J Gastroenterol Hepatol 1999; 11: 1277-82.